Executives Buy More Than $32M Of 3 Stocks Although US stocks closed sharply lower on Friday, there were a few notable insider trades. Benzinga · May 2, 2022
Expert Ratings for Nkarta Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: Benzinga · Apr 26, 2022
10 Biggest Price Target Changes For Tuesday HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading. Benzinga · Apr 26, 2022
Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses Nkarta Inc (NASDAQ:NKTX) has revealed the first human results from its two lead off-the-shelf NK cell therapies, with the high-dose regimens exhibiting multiple complete responses in blood cancer patients. For NKX101, three patients achieved a complete response (CR) among five AML patients who received three doses of either 1 billion or 1.5 billion… Benzinga · Apr 25, 2022
Benzinga's Daily Brief On Trending Tickers For April 25, 2022: Twitter, Coca-Cola, Nkarta, And More Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. Benzinga · Apr 25, 2022
Why Nkarta Stock Is Soaring Today Nkarta Inc (NASDAQ: NKTX) shares are trading higher Monday morning after the company announced positive preliminary Phase 1 data from independent dose finding studies. Benzinga · Apr 25, 2022